Efficacy of biological disease-modifying antirheumatic drugs: a systematic literature review informing the 2016 update of the EULAR recommendations for the management of rheumatoid arthritis.

There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

Abstract

To update the evidence for the efficacy of biological disease-modifying antirheumatic drugs (bDMARDs) in patients with rheumatoid arthritis (RA) to inform European League Against Rheumatism (EULAR) Task Force treatment recommendations.

Related collections

Author and article information

Journal

Journal ID (iso-abbrev): Ann. Rheum. Dis.

Title: Annals of the rheumatic diseases

Publisher: BMJ

ISSN (Electronic): 1468-2060

ISSN (Print): 0003-4967

Publication date (Electronic): Jun 2017

Volume: 76

Issue: 6

Affiliations

[1 ] Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Leeds, UK.

[2 ] NIHR Leeds Musculoskeletal Biomedical Research Unit, Leeds Teaching Hospitals NHS Trust, Leeds, UK.

[3 ] Center for Rheumatic Diseases, Yokohama City University Medical Center, Yokohama, Japan.

[4 ] .

[5 ] Unit for Clinical Therapy Research, Inflammatory Diseases (ClinTRID), The Karolinska Institute, Stokholm, Sweden.

[6 ] Division of Rheumatology, Department of Medicine 3, Medical University of Vienna, Vienna, Austria.

[7 ] Department of Medicine, Hietzing Hospital, Vienna, Austria.

[8 ] Department of Rheumatology, University Medical Center Utrecht, Utrecht, The Netherlands.

[9 ] Department of Rheumatology, Charité University Medicine Berlin, Berlin, Germany.

[10 ] Department of Rheumatology, Paris Descartes University, Cochin Hospital, Assistance Publique-Hôpitaux de Paris, INSERM (U1153): Clinical Epidemiology and Biostatistics, Paris, France.

[11 ] Department of Psychology, Health and Technology, University of Twente, Enschede, The Netherlands.

[12 ] EULAR Standing Committee of People with Arthritis/Rheumatism in Europe.

[13 ] Department of Clinical Immunology & Rheumatology, Amsterdam Rheumatology Center, Amsterdam, The Netherlands.

[14 ] Department of Rheumatology, Amsterdam Rheumatology Center, Amsterdam, The Netherlands.

[15 ] Department of Rheumatology, Zuyderland Medical Center, Heerlen, The Netherlands.

Article

Publisher Item ID: annrheumdis-2016-210713

DOI: 10.1136/annrheumdis-2016-210713

PubMed ID: 28283512

SO-VID: 3e8c961a-a876-4a02-bfcc-891ca8e8d562

History

Keywords: Anti-TNF,DMARDs (biologic),Rheumatoid Arthritis

Data availability:

Keywords: Anti-TNF, DMARDs (biologic), Rheumatoid Arthritis

Comments

Comment on this article

scite_

Cited by 87

See all cited by